The global swine health market is expected to register a CAGR of nearly 13.5 % during the forecast period, 2018-2023. As per the regional analysis, North America is expected to retain its dominance over the forecast period, primarily owing to intensifying consumer focus on food safety.
Intensifying Consumer Focus on Food Safety
In United States and Europe consumers are more aware about the food they consume and increasing interest in antibiotic-free food. China and India are expected to see a rise in use of antibiotics in agriculture with rise in middle class demand for meat. National level action plans and regulations are developed on use of antibiotics (correct dose rate) use and control of diseases. New diagnostic tests, such as detection of Swine Influenza Virus in nasal samples from pigs would be helpful to develop new medicines for treatment of resistant strains of viruses. The adoption of new policies and support from government for regulating food safety, particularly meat products are driving the swine health market.
Other driving factors include greater livestock production rates, increasing foodborne diseases, and increasing export demand for pork.
Regulatory Challenges
The swine disease virus is endemic in United States, Asia, and Europe. A variety of ready-to-eat processed meats, mainly made from pork, after being identified as the source of disease outbreak of swine are recalled, which led to losses to the market. The US Department of Agriculture (USDA) had tried to keep PEDV and related diseases out of the country by restricting imports of pigs and pork products from China. In South Dakota potential swine virus affecting farms are porcine epidemic diarrhea virus and porcine delta coronavirus. Thus, the aforementioned factors are pulling back the market growth, globally.
Other factor impeding this market include cost-effective production
United States is the Chief Region for Swine Health Market
North America is expected to dominate the market due to rising incidence of swine infections, such as Swine Enteric Coronavirus Diseases (SECD), porcine epidemic diarrhea (PEDv), porcine delta coronavirus (PDCoV), which has caused significant morbidity and mortality, particularly in young piglets. The virus is endemic in swine populations in North America. In United States the Swine Health Protection Act (SHPA) regulates the meat products fed to swine. Compliance with this act ensures that all food waste fed to swine is properly treated to kill disease organisms. Raw meat may transmit numerous infectious or communicable diseases to swine. Over the forecast period, with the rise in incidence of swine, US is expected to be major revenue generating region for the swine health market.
.jpg)
Key Developments in the Market
- April 2018 – Zoetis built sustainable veterinary diagnostic network and animal health infrastructure in Uganda, Nigeria, and Ethiopia
Major Players: Zoetis, Merck, Merial, Elanco, Bayer Animal Health, Boehringer Ingelheim, Vetmedica, Novartis Animal Health, Virbac, Ceva Sante Animale, and Vetoquinol, amongst others.
Reasons to Purchase this Report
- Current and future of swine health market outlook in the developed and emerging markets
- Analysis of various perspectives of the market with the help of Porter’s five forces analysis
- The segment that is expected to dominate the market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, market shares, and strategies employed by the major market players
- 3-month analyst support, along with the Market Estimate sheet in excel
Customization of the Report
- This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs
1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Degree of Competition
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Intensifying Consumer Focus on Food Safety
6.1.2 Greater Livestock Production Rates
6.1.3 Increasing Foodborne Diseases
6.1.4 Increasing Export Demand For Pork
6.2 Market Restraints
6.2.1 Regulatory Challenges
6.2.2 Cost Effective Production
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Products
7.1.1 By Therapeutics
7.1.1.1 Vaccines
7.1.1.2 Parasiticides
7.1.1.3 Anti-infectives
7.1.1.4 Medicinal Feed Additives
7.1.1.5 Others
7.1.2 By Application
7.1.2.1 Diseases Caused by Bacteria, Mycoplasmas, and Spirochetes
7.1.2.2 Domestic Viral Diseases
7.1.2.3 Parasitic Diseases
7.1.2.4 Nutritional Deficiencies
7.1.2.5 Toxicoses and Poisonings
7.1.2.6 Exotic Viral Diseases
7.1.2.7 Skin Diseases
7.1.2.8 Others
7.2 By Geography
7.2.1 North America
7.2.1.1 United States
7.2.1.2 Canada
7.2.1.3 Mexico
7.2.2 Europe
7.2.2.1 Germany
7.2.2.2 France
7.2.2.3 United Kingdom
7.2.2.4 Italy
7.2.2.5 Spain
7.2.2.6 Rest of Europe
7.2.3 Asia-Pacific
7.2.3.1 India
7.2.3.2 China
7.2.3.3 Japan
7.2.3.4 Australia
7.2.3.5 South Korea
7.2.3.6 Rest of Asia-Pacific
7.2.4 Middle East & Africa
7.2.4.1 GCC
7.2.4.2 South Africa
7.2.4.3 Rest of Middle East & Africa
7.2.5 South America
7.2.5.1 Brazil
7.2.5.2 Argentina
7.2.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers and Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Bayer Animal Health
9.2 Boehringer Ingelheim
9.3 Ceva Sante Animale
9.4 Elanco
9.5 Merck
9.6 Merial
9.7 Novartis Animal Health
9.8 Vetmedica
9.9 Vetoquinol
9.10 Virbac
9.11 Zoetis
10. Future of the Market
